4//SEC Filing
SACANE SCOTT 4
Accession 0001005477-03-003562
CIK 0001012131other
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 9:21 PM ET
Size
10.9 KB
Accession
0001005477-03-003562
Insider Transaction Report
Form 4
DURUS CAPITAL MANAGEMENT
10% Owner
Transactions
- Purchase
Common Stock
2002-10-28$3.83/sh+90,200$345,015→ 1,463,280 total(indirect: See Footnote) - Purchase
Common Stock
2002-10-28$3.90/sh+16,500$64,345→ 1,373,080 total(indirect: See Footnote) - Purchase
Common Stock
2002-10-28$4.07/sh+100$407→ 1,356,580 total(indirect: See Footnote)
SACANE SCOTT
10% Owner
Transactions
- Purchase
Common Stock
2002-10-28$3.83/sh+90,200$345,015→ 1,463,280 total(indirect: See Footnote) - Purchase
Common Stock
2002-10-28$4.07/sh+100$407→ 1,356,580 total(indirect: See Footnote) - Purchase
Common Stock
2002-10-28$3.90/sh+16,500$64,345→ 1,373,080 total(indirect: See Footnote)
Footnotes (4)
- [F1]This Form 4 is being filed by Durus Capital Management LLC ("Capital") and Scott Sacane.
- [F2]In accordance with instruction 4(b)(iv) of Form 4, these amounts reflect the aggregate amount of shares controlled by Capital (and by Scott Sacane through Capital) under Section 13(d) of the Exchange Act. Each Reporting Person disclaims beneficial ownership under Section 16 of the Exchange Act with respect to such transactions or securities, as applicable, to the extent greater than their indirect pecuniary interest therein.
- [F3]Through Durus Life Sciences Master Fund Ltd.
- [F4]The Reporting Persons are currently unable to determine the exact time of day that these transactions were effected. The Reporting Persons disclaim the applicability of Section 16 to these transactions to the extent the transactions occurred when Section 16 was inapplicable to such transactions.
Issuer
NOVOSTE CORP /FL/
CIK 0001012131
Entity typeother
Related Parties
1- filerCIK 0001160291
Filing Metadata
- Form type
- 4
- Filed
- Aug 21, 8:00 PM ET
- Accepted
- Aug 22, 9:21 PM ET
- Size
- 10.9 KB